Table 1. Characteristics of eligible studies.
Publication | Year | Country | Cancer subtype | No. of patients | Median age (years) | Median follow-up (years) | Outcome | Survival analysis | NOS (score) |
---|---|---|---|---|---|---|---|---|---|
Markiewicz | 2012 | Poland | II-III BC | 36 | 56.5 | 4.2 | DFS, OS | multivariate | 8 |
Montserrat | 2011 | Spain | invasive BC | 76 | 67 | 4.5 | DFS, OS | multivariate | 8 |
Riaz | 2012 | Netherlands | primary BC | 1427 | 55 | 8.7 | DFS, OS | multivariate | 8 |
Soini | 2011 | Finland | invasive BC | 387 | NR | NR | OS | univariate | 7 |
Xu | 2014 | China | primary BC | 137 | NR | 5 | DFS, OS | multivariate | 8 |
Zhang | 2015 | China | invasive BC | 408 | 50 | 1.3 | DFS, OS | univariate | 7 |
Zhao | 2013 | China | primary BC | 200 | 50 | NR | OS | univariate | 7 |
BC, breast cancer; NR, not reported; DFS, disease-free survival; OS, overall survival; NOS, Newcastle Ottawa Scale